Brain Wave Monitoring for Traumatic Brain Injury
(INDICT Trial)
Trial Summary
What is the purpose of this trial?
This study is a randomized Phase 2 trial to determine the feasibility of real-time electrocorticographic monitoring of spreading depolarizations (SD) to guide implementation of a tier-based protocol of intensive care therapies, aimed at SD suppression, for the management of patients who have undergone acute operative treatment of severe traumatic brain injury.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Full-band Electrocorticography, Electrocorticography, ECoG, Intracranial EEG, Treatment Algorithm, Ketalar, Special K for traumatic brain injury?
Research suggests that using a variety of monitoring techniques, including brain wave monitoring, can improve outcomes for traumatic brain injury patients by allowing for more personalized care. Although specific drugs or treatments like Ketalar (a form of anesthesia) are not directly proven effective in the studies, the overall strategy of multimodal monitoring is associated with better patient outcomes.12345
How is the drug Ketalar (Special K) unique in treating traumatic brain injury?
Eligibility Criteria
This trial is for individuals who need emergency surgery (craniotomy) to treat severe traumatic brain injury within 72 hours after the injury. It's not for those with non-survivable injuries, those who've had a certain type of skull surgery due to swelling, are in another TBI study, or are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo intensive care with real-time electrocorticographic monitoring to guide therapy for spreading depolarization suppression
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Full-band Electrocorticography
- Treatment Algorithm
Treatment Algorithm is already approved in United States, European Union, Canada for the following indications:
- Anesthesia
- Pain management
- Sedation
- Anesthesia
- Pain management
- Sedation
- Anesthesia
- Pain management
- Sedation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Cincinnati
Lead Sponsor
University of New Mexico
Collaborator
University of Pennsylvania
Collaborator